HEALTHCARE & PHARMACEUTICALS MARKET RESEARCH
Category: Healthcare
-
WHY IS OUR IMMUNE SYSTEM ATTACKING US?
When a foreign substance enters our body, it identifies the danger and our immune system then produces antibodies in response to the antigen that may be present on the surface of that substance. This is our body’s way of fighting against the infection and it is what we call an immune response. The antigen induces…
-
ZOLGENSMA: THE WORLD’S MOST EXPENSIVE DRUG @ £1.79 Million (Rs 18 Cr)
What is Zolgensma? It is an FDA-approved drug which is basically a type of gene replacement therapy used to treat spinal muscular atrophy(SMA) in paediatric patients. A single dose of this drug can provide a lifetime of benefit and save lives. The drug’s original developer is Avexis which has been acquired by Novartis in May…
-
NIPAH VIRUS : ALL THE INFORMATION YOU NEED
History of the Nipah virus in India In 2001, the first outbreak of Nipah virus was occurred in West Bengal that caused as many as 45 deaths. Again, it happened there in 2007 and 5 people lost their lives. In Kozhikode, it all started in May, 2018 when the first Nipah virus disease outbreak was…
-
FIRST DEATH DUE TO NIPAH VIRUS IN KERALA
A 12 year old boy, Muhammad Hashim dies of Nipah virus in Kozhikode on Sunday morning. The Central Government has confirmed the case and a team of National Centre for Disease Control was rushed to kerala for technical support. Kerala’s health minister, Veena George has also went to assess the situation. A team including health…
-
INDIA’S FIRST CASE OF H5N1 AVIAN INFLUENZA IN HUMAN
First case of human infection of influenza A(H5N1) virus in India has been reported on July 21, 2021. The patient was a 18 year old male from Harayana. Symptoms observed(in June) were fever, cough, difficulty in breathing and other upper respiratory symptoms after he was given an immunosuppressive treatment for an underlying illness. Patient’s condition further deteriorated leading to acute respitatory distress syndrome(ARDS).…
-
ACTIVE COVID-19 CASES CROSS THE 2 LAKH MARK IN KERALA
With a daily count of over 30,000 cases for the fourth consecutive day, Kerala accounts for around 70% of he total COVID-19 cases in the country. Active cases are over 2 lakhs and the latest positivity rate recorded on a day was 18.67%. “Since the relaxations in lockdown, there has been surge in cases. It was further increased after Onam,” says Vijayan…
-
Pfizer-BioNTech vaccine becomes the first vaccine to receive full FDA validation
The vaccine by Pfizer-BioNTech is the first vaccine that has been lincensed for COVID-19. The mRNA vaccine has shown to prevent 95 percent of COVID-19 during the clinical trials and can be administered in people aged 16 and older. It has also been given emergency use authorisation for use in adolescents in December last year. The two dose vaccine can be given…
-
BIOCON-VIATRIS SEMGLEE GETS USFDA APPROVAL AS FIRST INTERCHANGEABLE BIOSIMILAR PRODUCT
Biocon Biologics and Viatris Inc. have received approval from the US Food and Drug Administration for the first interchangeable biosimilar Semglee which is an insulin glargine-yfgn injection for treating diabetes. This will allow pharmacy level substitution and provide convenient access to Semglee. The product launch is expected to happen by the end of the year. “This interchangeability…
-
MODERNA TO USE mRNA FOR HIV AND CANCER AFTER COVID-19
Moderna has developed several drugs with its cost and time effective mRNA technology that are currently undergoing trials for HIV, cancer, heart diseases and genetic disorders that could potentially lead to a paradigm shift in the way medicines are developed and manufactured. The company currently has vaccines for 10 viruses in trials including one for…
Follow Us
Recent Posts
-
Bedaquiline Role in Treating Tuberculosis having a hefty $1.38 billion dollar market
-
Adalimumab’s competition and immense market Growth Potential of 5.1%
-
Semaglutide’s massive influence on the Diabetes Pharmaceutical Market and 6 competitors
-
FDA approved Leqembi to have $12.9 billion sales
-
Assistive Technology Market; a $82B Growth Story
Tags
Autoimmunity cancer cancer research cancer therapy CDSCO covid-19 covid in children Diabetes drug Elderly Health FDA healthcare immune response Kerala mutations Nipah virus pandemic PCOS pharma Pharmaceutical market pharma sector protein-based vaccines sars-cov-2 therapy third wave Treatment vaccine variants WHO zydus cadila